Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Horizontal vs Vertical Scleral Tunnels in Flanged IOL Fixation (HORVER)

7 juli 2026 uppdaterad av: Sebahattin Celik MD, Yuzuncu Yil University

Horizontal Versus Vertical Scleral Tunnel Orientation in Flanged Intrascleral Fixation: A 2-Year Comparative Study

This study compares the 2-year outcomes of horizontal versus vertical scleral tunnel orientation in flanged intrascleral intraocular lens (IOL) fixation surgery. The primary outcome is the proportion of eyes achieving refraction within ±0.50 diopters of the target at 2 years. Secondary outcomes include IOL tilt measured by anterior segment optical coherence tomography (AS-OCT), iris capture, conjunctival erosion, and other complications. The study aims to determine whether tunnel orientation is associated with differing outcomes in this surgical technique.

Studieöversikt

Detaljerad beskrivning

Background: The management of aphakia, crystalline lens luxation, and intraocular lens (IOL) luxation in the absence of adequate capsular support remains challenging. Traditional surgical options include anterior chamber IOLs, iris-fixated IOLs, and scleral-sutured posterior chamber IOLs, each carrying significant long-term risks. In 2017, Yamane and colleagues introduced a sutureless flanged intrascleral IOL fixation technique that rapidly gained worldwide acceptance. A critical yet under-investigated surgical variable is the orientation of the scleral tunnels relative to the limbus. Some surgeons create tunnels parallel to the limbus (horizontal/tangential), others perpendicular (vertical/radial), based on personal preference rather than high-level evidence.

Objective: To evaluate whether horizontal versus vertical scleral tunnel orientation is associated with differing 2-year outcomes in flanged intrascleral IOL fixation.

Study Design: This is a retrospective observational cohort study conducted at a single tertiary referral centre.

Participants: A total of 107 eyes (43 vertical tunnels, 64 horizontal tunnels) with complete 24-month follow-up are included. Surgeries are performed by two experienced vitreoretinal surgeons.

Interventions: All procedures follow the original Yamane flanged intrascleral fixation method with intentional variation in tunnel orientation only. The horizontal tunnel group receives tunnels parallel to the limbus (tangential), while the vertical tunnel group receives tunnels perpendicular to the limbus (radial). A three-piece foldable acrylic IOL (Alcon AcrySof MA60AC) is used in all eyes.

Outcome Measures: The primary outcome is the proportion of eyes achieving mean absolute error (MAE) within ±0.50D of target refraction at 2 years. Secondary outcomes include MAE at 2 years, IOL tilt measured using anterior segment optical coherence tomography (AS-OCT), iris capture, conjunctival erosion, cystoid macular oedema, epiretinal membrane, retinal detachment, vitreous haemorrhage, hypotony, corneal oedema, early IOP elevation, best-corrected visual acuity (BCVA), and vector astigmatism analysis using the Alpins method.

Statistical Analysis: Propensity score matching (1:1) will be performed to address selection bias. Multivariate logistic regression and a multilevel mixed-effects model with surgeon as random effect will be used to adjust for confounders including surgical period, age, and baseline refraction. For the primary outcome, a single pre-specified comparison will be made with a two-tailed significance level of α = 0.05. For secondary outcomes, the False Discovery Rate (FDR) using the Benjamini-Hochberg procedure (q = 0.05) will be applied to control for Type I error inflation.

Timeline: Data were collected from patients who underwent surgery between March 1, 2022, and March 1, 2025. Minimum follow-up is 24 months, with final data collection completed in March 2025.

Studietyp

Observationell

Inskrivning (Faktisk)

107

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studieorter

      • Van, Turkiet (Türkiye), 65000
        • SBU Van Training and Research Hospital

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

  • Vuxen
  • Äldre vuxen

Tar emot friska volontärer

Nej

Testmetod

Icke-sannolikhetsprov

Studera befolkning

Patients with aphakia, crystalline lens luxation, or intraocular lens luxation in the absence of adequate capsular support who underwent flanged intrascleral IOL fixation surgery at a single tertiary referral centre between March 1, 2022, and March 1, 2025. All patients were aged 18 years or older and completed 24 months of follow-up.

Beskrivning

Inclusion Criteria:

  • Age ≥ 18 years
  • Complicated aphakia defined as absence of adequate capsular support following cataract extraction, lens trauma, or previous lensectomy
  • Crystalline lens luxation defined as partial or complete displacement of the natural lens due to zonular weakness
  • Intraocular lens (IOL) luxation defined as partial or complete dislocation of a previously implanted IOL
  • Inadequate capsular support (<180° of intact zonular or capsular support)
  • Ability to complete scheduled follow-up visits
  • Complete follow-up data available

Exclusion Criteria:

  • Previous scleral buckling surgery within 6 months
  • Pars plana vitrectomy within 3 months
  • Active uveitis
  • Active endophthalmitis
  • Uncontrolled scleritis or scleral thinning
  • Corneal decompensation (endothelial cell density <1000 cells/mm²)
  • Uncontrolled glaucoma (IOP >25 mmHg despite maximum therapy)
  • History of penetrating keratoplasty, DALK, DSEK, or DMEK
  • History of corneal refractive surgery
  • Active proliferative diabetic retinopathy
  • Pregnancy or breastfeeding
  • Inability to complete 24-month follow-up

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

Kohorter och interventioner

Grupp / Kohort
Intervention / Behandling
Vertical Scleral Tunnel Group
Patients who underwent flanged intrascleral IOL fixation with scleral tunnels created perpendicular to the limbus (radial/vertical orientation).
Sutureless flanged intrascleral fixation of a three-piece foldable acrylic IOL (Alcon AcrySof MA60AC). Two partial-thickness scleral tunnels are created 2.0 mm posterior to the limbus, 180° apart. Haptics are externalized through the tunnels, and a flange is created on each haptic tip using thermal cautery. Tunnel orientation varied intentionally: horizontal (parallel to limbus) or vertical (perpendicular to limbus).
Horizontal Scleral Tunnel Group
Patients who underwent flanged intrascleral IOL fixation with scleral tunnels created parallel to the limbus (tangential/horizontal orientation).
Sutureless flanged intrascleral fixation of a three-piece foldable acrylic IOL (Alcon AcrySof MA60AC). Two partial-thickness scleral tunnels are created 2.0 mm posterior to the limbus, 180° apart. Haptics are externalized through the tunnels, and a flange is created on each haptic tip using thermal cautery. Tunnel orientation varied intentionally: horizontal (parallel to limbus) or vertical (perpendicular to limbus).

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Proportion of Eyes Achieving Mean Absolute Error (MAE) Within ±0.50 Diopters of Target Refraction
Tidsram: 24 Months
The proportion of eyes achieving mean absolute error (MAE) within ±0.50 diopters of the target spherical equivalent refraction at 24 months postoperatively.
24 Months

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Mean Absolute Error (MAE) at 2 Years
Tidsram: 24 Months
Mean absolute error in spherical equivalent refraction at 24 months postoperatively.
24 Months
IOL Tilt Angle
Tidsram: 24 Months
Intraocular lens tilt angle measured using anterior segment optical coherence tomography (AS-OCT) at 24 months postoperatively.
24 Months

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Publikationer och användbara länkar

Den som ansvarar för att lägga in information om studien tillhandahåller frivilligt dessa publikationer. Dessa kan handla om allt som har med studien att göra.

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Faktisk)

1 mars 2022

Primärt slutförande (Faktisk)

1 mars 2025

Avslutad studie (Faktisk)

1 mars 2025

Studieregistreringsdatum

Först inskickad

1 juli 2026

Först inskickad som uppfyllde QC-kriterierna

7 juli 2026

Första postat (Faktisk)

14 juli 2026

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

14 juli 2026

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

7 juli 2026

Senast verifierad

1 juli 2026

Mer information

Termer relaterade till denna studie

Andra studie-ID-nummer

  • GOKAEK-2024-04-02 (Annan identifierare: Van Training and Research Hospital Ethics Committee)

Plan för individuella deltagardata (IPD)

Planerar du att dela individuella deltagardata (IPD)?

NEJ

IPD-planbeskrivning

Individual participant data will not be shared due to institutional data protection policies and patient privacy regulations. Anonymized aggregate data may be available from the corresponding author upon reasonable request.

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera